Aptar serves a number of attractive end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Using market expertise, proprietary design, engineering and science ...

LTR Pharma and Aptar Pharma have entered into a co-development agreement for Spontan The primary goal is commercialisation of ...

Digitalisation of health is one of Chiesi's core R&D objectives, and the alliance with Aptar isn't its first in the respiratory category, its largest therapeutic area accounting for €1.7 billion ...

Aptar said that adding Voluntis to its stable would allow help it develop a new generation of DTX for pharmaceutical and biotech customers, as well as other healthcare stakeholders including ...

Aptar Pharma, leader in respiratory drug delivery solutions, and RDD Online® are pleased to announce their co-organization of RDD® Europe 2025, which will be held in-person from Tuesday ...

Beth Holland, Aptar's Chief Sustainability Officer, remarked, "We have already achieved over 95% annual sourcing of renewable electricity within our operations with a target of sourcing 100% by 2030.

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, ...

The conference will open with a Welcome Cocktail Reception on the evening of Tuesday, May 6, and Aptar Pharma will sponsor a Gala Dinner at a scenic location in Estoril on Thursday, May 8.

CRYSTAL LAKE, Ill., February 27, 2025--(BUSINESS WIRE)--Aptar Pharma, leader in respiratory drug delivery solutions, and RDD Online ® are pleased to announce their co-organization of RDD ® Europe 2025 ...